Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH). JCO 41 , 117-127 (2023). DOI: ...

Lenvatinib (LEN) is a first-line therapy for patients with advanced hepatocellular carcinoma (HCC); however, it has shown modest survival benefits. Therefore, we aimed to compare clinical outcomes of ...

As an alternative to surgery, percutaneous or laparoscopic radio frequency ablation or alcohol injection may be used as curative therapy for early HCC. For unresectable HCC that is unsuitable for ...

Chemoembolization in the head and neck area can be carried out routinely using this method. British Journal of Cancer - Monocomponent chemoembolization in oral and oropharyngeal cancer using an ...

NEW YORK (Medscape Wire) May 22 -- Chemoembolization should be the standard approach in selected patients with unresectable hepatocellular carcinoma, based on improved survival in a randomized ...

Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World Journal of Gastroenterology, 2010; 16 (25): 3161 DOI: 10.3748/wjg.v16.i25.3161 ...

Nov. 6, 2002 (Boston) — When surgery is not an option for treatment of hepatocellular carcinoma, arterial chemoembolization, but not tamoxifen, may prolong survival of patients with advanced ...